The remodeling transient and the calcium economy
Tóm tắt
The remodeling transient describes a change in bone mass that lasts one remodeling cycle following an intervention that disturbs the calcium economy. We demonstrated the transient in a study of the response of bone density to calcium/vitamin D3 supplementation and show the hazards of misinterpretation if the transient is not considered. The remodeling transient describes a change in bone mass that lasts for one remodeling cycle following an intervention that disturbs the calcium economy. We report an intervention with calcium and vitamin D supplementation in 208 postmenopausal African-American women where the remodeling transient was considered a priori in the study design. Both groups (calcium alone vs. calcium + 20 μg (800 IU) vitamin D3) were ensured a calcium intake in excess of 1200 mg/day. There were no differences between the two groups in changes in BMD over time. These BMD changes were therefore interpreted to reflect increased calcium intake in both groups but not any influence of vitamin D. A transient increase in bone mineral density was observed during the first year of study, followed by a decline. The remodeling period was estimated at about 9 months, which is similar to histomorphometric estimates. It is problematic to draw conclusions concerning interventions that influence the calcium economy without considering the remodeling transient in study design. Studies of agents that effect bone remodeling must be carried out for at least two remodeling cycles and appropriate techniques must be used in data analysis.
Tài liệu tham khảo
Parfitt A (2002) Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone 30(1):5–7
Frost H (1989) Some effects of basic multicellular unit-based remodelling on photon absorptiometry of trabecular bone. Bone Miner 7(1):47–65
Heaney RP (1994) The bone-remodeling transient: implications for the interpretation of clinical studies of bone mass change. J Bone Miner Res 9(10):1515–1523
Parfitt AM (2004) What is the normal rate of bone remodeling? Bone 35:1–3
Frost H (1973) The origin and nature of transients in human bone. remodelling dynamics. In: Frame B, Parfitt AM, Duncan H (eds) Clinical Aspects of Metabolic Bone Disease. Excerpta Medica, Amsterdam, pp 124–140
Heaney RP (2003) Is the paradigm shifting? Bone 33:457–465
Heaney RP, Yates AJ, Santora AC 2nd (1997) Bisphosphonate effects and the bone remodeling transient. J Bone Miner Res 12(8):1143–1151
Aloia JF, Talwar SA et al (2005) A randomized controlled trial of vitamin D3 supplementation in African-American women. Arch Intern Med 165:1618–1623
Kao PC, Jiang NS, Klee GG, Purnell DC (1982) Development and validation of a new radioimmunoassay for parathyrin (PTH). Clin Chem 28(1):69–74
Hollis B (1984) Relative concentrations of 25-hydroxyvitamin D2/D3 and 1,25-dihydroxyvitamin D2/D3 in maternal plasma at delivery. Nutr Res 4:27
McCall RB (1975) Fundamental Statistics for Psychology, 2nd edn. Harcourt Brace Jovanovitch, New York, p 228
Dawson-Hughes B, Harris SS, Krall E, Dallal G (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337(10):670–676
Jones G, Nguyen T, Sambrook P et al (1994) Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 309:691–695
Greenspan SL, Maitland LA, Myers ER et al (1994) Femoral bone loss progresses with age: a longitudinal study in women over age 65. J Bone Miner Res 9:1959–1965
Mackerras D, Lumley T (1997) First- and second-year effects in trials of calcium supplementation on the loss of bone density in postmenopausal women. Bone 21:527–533
Aloia JF, Vaswani A, Yeh JK et al (1994) Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Intern Med 120(2):97–103
Dawson-Hughes B, Dallal GE, Krall EA et al (1990) A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323(13):878–883
Elders P, Netelenbos J, Lips P et al (1991) Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46–55 years of age. J Clin Endocrinol Metab 73:533–540
Hansson T, Roos B (1987) The effect of fluoride and calcium on spinal mineral content: A controlled, prospective (3 years) study. Calcif Tissue Int 40:315–317
Prince RL, Devine A, Dick I et al (1995) The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women. J Bone Miner Res 10:1068–1075
Prince RL, Smith M, Dick I et al (1991) Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N Engl J Med 325:1189–1195
Reid IR, Ames RW, Evans MC et al (1993) Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 328(7):460–464
Riis BJ, Thomsen K, Christiansen C (1987) Does calcium supplementation prevent postmenopausal bone loss? N Engl J Med 316:173–177
Heaney RP (2001) The bone remodeling transient: interpreting interventions involving bone-related nutrients. Nutr Rev 59(10):327–333
Elders P, Netelenbos J, Van Ginkel F et al (1994) Long-term effect of calcium supplementation on bone loss in perimenopausal women. J Bone Miner Res 9(7):963–970
Johnston CC, Miller J, Slemenda CW et al (1992) Calcium supplementation and increases in bone mineral density in children. N Engl J Med 327:82–87
Peacock M, Liu G, Carey M et al (2000) Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab 85:3011–3019
Dawson-Hughes B, Harris SS, Krall E, Dallal GE (2000) Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women. Am J Clin Nutr 72(3):745–750
Reid IR, Ames RW, Evans MC et al (1995) Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med 98(4):331–335
Dawson-Hughes B, Harris SS, Krall E, Dallal G (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337(10):670–676
Jackson R, LaCroix A, Gass M et al (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354(7):669–683
McKane WR, Khosla S, Egan KS et al (1996) Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metab 81(5):1699–1703
Kimmel D, Recker R, Gallagher J et al (1990) A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects. Bone Miner 11(2):217–235
Han ZH, Palnitkar S, Rao DS et al (1997) Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss. J Bone Miner Res 12(4):498–508
Weinstein R, Bell N (1988) Diminished rates of bone formation in normal black adults. N Engl J Med 319(26):1698–1701
Aloia, JF, Vaswani A, Feuerman M et al (2000) Differences in skeletal and muscle mass with aging in black and white women. Am J Physiol Endocrinol Metab 278(6):E1153–1157
Pattanaungkul S, Riggs BL, Yergey AL et al (2000) Relationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D [1.25(OH)2D] levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D action. J Clin Endocrinol Metab 85(11):4023–4027
Martini L, Wood RJ (2002) Relative bioavailability of calcium-rich dietary sources in the elderly. Am J Clin Nutr 76(6): 1345–1350
Aloia J, Vaswani, A, Yeh J, Russo L (1996) Differential effects of dietary calcium augmentation and hormone replacement therapy on bone turnover and serum levels of calcitrophic hormones. Osteoporos Int 6:55–62
McClung M, Lewiecki E, Cohen S et al (2006) Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 354:821–831